IMAGE

Fig. 4

ID
ZDB-IMAGE-101115-32
Genes
Antibodies
Source
Figures for Scholpp et al., 2009
Image
Figure Caption

Fig. 4

Her6 acts to genetically suppress neurog1. Analysis of ascl1a and irx1b, a pan-thalamic marker, at 30 hpf (A–D) and vglut2.1 and GAD65/67 at 48 hpf (E–H) in her6 and neurog1 morphant embryos. Knock-down of her6 leads to the down-regulation of ascl1a (45/61; A and B) as well as GAD65/67 (22/35; E and F) in the rTh (arrowheads) and in the PTh. Knock-down of neurog1 leads to an unaltered PTh but an increase in width in ascl1a expression (22/34; C) as well as GAD65/67 expression (12/21; G) in the rTh (yellow arrows). Compared to the her6 single knock-down, double knock-down of her6 and neurog1 rescues the prethalamic as well as the rostral thalamic expression domain (ascl1a: 17/22; GAD: 8/17; D and H). Analysis of the MDO in shh:GFP transgenic animals co-expressing ubiquitously the membrane-bound fluorophore mCherry (I–L): Down-regulation of her6 leads to disintegration of the Shh positive MDO (20/26; I and J; arrowheads). In embryos knocked-down for neurog1, the MDO seems unaltered in extension and width compared to the control (8/10; K, arrowhead). Double knock-down of her6 and neurog1 rescues the extend of the shh:GFP expression within the MDO (6/8; L, arrowhead). III, third ventricle; cTh, caudal thalamus; MDO, mid-diencephalic organizer; PTh, prethalamus; rTh, rostral thalamus.

Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Proc. Natl. Acad. Sci. USA